Bristol Myers Squibb (BMY) EBT Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,755.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-3,737.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-552.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5,950.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-3.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,234.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
372.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
168.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
168.00 |
| Dec 31, 2025 |
1,034.00 |
| Sep 30, 2025 |
1,139.00 |
| Jun 30, 2025 |
391.00 |
| Mar 31, 2025 |
12,358.00 |
| Dec 31, 2024 |
-1,317.00 |
| Sep 30, 2024 |
-539.00 |
| Jun 30, 2024 |
-602.00 |
| Mar 31, 2024 |
-12,149.00 |
| Dec 31, 2023 |
-171.00 |
| Sep 30, 2023 |
-20.00 |
| Jun 30, 2023 |
9.00 |
| Mar 31, 2023 |
995.00 |
| Dec 31, 2022 |
80.00 |
| Sep 30, 2022 |
114.00 |
| Jun 30, 2022 |
320.00 |
| Mar 31, 2022 |
-837.00 |
| Dec 31, 2021 |
10,993.00 |
| Sep 30, 2021 |
-286.00 |
| Jun 30, 2021 |
-279.00 |
| Mar 31, 2021 |
2,567.00 |
| Dec 31, 2020 |
-9,280.00 |
| Sep 30, 2020 |
-104.00 |
| Jun 30, 2020 |
-1,225.00 |
| Mar 31, 2020 |
-3,625.00 |
| Dec 31, 2019 |
-2,682.00 |
| Sep 30, 2019 |
-1,562.00 |
| Jun 30, 2019 |
1,925.00 |
| Mar 31, 2019 |
-83.00 |
| Dec 31, 2018 |
1,239.00 |
| Sep 30, 2018 |
1,556.00 |
| Jun 30, 2018 |
-1,611.00 |
| Mar 31, 2018 |
-541.00 |
| Dec 31, 2017 |
-790.00 |
| Sep 30, 2017 |
-916.00 |
| Jun 30, 2017 |
-798.00 |
| Mar 31, 2017 |
197.00 |
| Dec 31, 2016 |
3,028.00 |
| Sep 30, 2016 |
742.00 |
| Jun 30, 2016 |
3,191.00 |
| Mar 31, 2016 |
186.00 |
| Dec 31, 2015 |
-815.00 |
| Sep 30, 2015 |
-145.00 |
| Jun 30, 2015 |
-1,027.00 |
| Mar 31, 2015 |
999.00 |
| Dec 31, 2014 |
-2,098.00 |
| Sep 30, 2014 |
558.00 |
| Jun 30, 2014 |
-157.00 |
| Mar 31, 2014 |
825.00 |
| Dec 31, 2013 |
733.00 |
| Sep 30, 2013 |
5,382.00 |
| Jun 30, 2013 |
-1,074.00 |
| Mar 31, 2013 |
-2,101.00 |
| Dec 31, 2012 |
-1,699.00 |
| Sep 30, 2012 |
-6,794.00 |
| Jun 30, 2012 |
-911.00 |
| Mar 31, 2012 |
334.00 |
| Dec 31, 2011 |
4,537.00 |
| Sep 30, 2011 |
60.00 |
| Jun 30, 2011 |
-45.00 |
| Mar 31, 2011 |
506.00 |
| Dec 31, 2010 |
-4,237.00 |
| Sep 30, 2010 |
95.00 |
| Jun 30, 2010 |
76.00 |
| Mar 31, 2010 |
256.00 |
